- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis finalise l’acquisition de LimaCorporate S.p.A.
- Enovis Conclui Aquisição da LimaCorporate S.p.A
More ▼
Key statistics
On Wednesday, Enovis Corp (ENOV:NYQ) closed at 56.17, -15.07% below its 52-week high of 66.14, set on Jul 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.44 |
---|---|
High | 56.24 |
Low | 55.14 |
Bid | 52.62 |
Offer | 57.31 |
Previous close | 55.47 |
Average volume | 498.03k |
---|---|
Shares outstanding | 54.84m |
Free float | 51.70m |
P/E (TTM) | -- |
Market cap | 3.04bn USD |
EPS (TTM) | -0.9987 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 00:00 BST.
More ▼